Skip Nav Destination
Genetic engineering of T-cell receptors: TCR takes to titin
Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a
Issue Archive
August 8 2013
In this Issue
Table of Contents
INSIDE BLOOD
CLINICAL TRIALS & OBSERVATIONS
Genetic engineering of T-cell receptors: TCR takes to titin
Clinical Trials & Observations
BLOOD WORK
PLENARY PAPER
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
Gerald P. Linette,Edward A. Stadtmauer,Marcela V. Maus,Aaron P. Rapoport,Bruce L. Levine,Lyndsey Emery,Leslie Litzky,Adam Bagg,Beatriz M. Carreno,Patrick J. Cimino,Gwendolyn K. Binder-Scholl,Dominic P. Smethurst,Andrew B. Gerry,Nick J. Pumphrey,Alan D. Bennett,Joanna E. Brewer,Joseph Dukes,Jane Harper,Helen K. Tayton-Martin,Bent K. Jakobsen,Namir J. Hassan,Michael Kalos,Carl H. June
REVIEW ARTICLE
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Michele Baccarani,Michael W. Deininger,Gianantonio Rosti,Andreas Hochhaus,Simona Soverini,Jane F. Apperley,Francisco Cervantes,Richard E. Clark,Jorge E. Cortes,François Guilhot,Henrik Hjorth-Hansen,Timothy P. Hughes,Hagop M. Kantarjian,Dong-Wook Kim,Richard A. Larson,Jeffrey H. Lipton,François-Xavier Mahon,Giovanni Martinelli,Jiri Mayer,Martin C. Müller,Dietger Niederwieser,Fabrizio Pane,Jerald P. Radich,Philippe Rousselot,Giuseppe Saglio,Susanne Saußele,Charles Schiffer,Richard Silver,Bengt Simonsson,Juan-Luis Steegmann,John M. Goldman,Rüdiger Hehlmann
CLINICAL TRIALS AND OBSERVATIONS
Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a
Clinical Trials & Observations
Alfonso Quintás-Cardama,Omar Abdel-Wahab,Taghi Manshouri,Outi Kilpivaara,Jorge Cortes,Anne-Laure Roupie,Su-Jiang Zhang,David Harris,Zeev Estrov,Hagop Kantarjian,Ross L. Levine,Srdan Verstovsek
HEMATOPOIESIS AND STEM CELLS
Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients
Loïc Garçon,Jingping Ge,Shwetha H. Manjunath,Jason A. Mills,Marisa Apicella,Shefali Parikh,Lisa M. Sullivan,Gregory M. Podsakoff,Paul Gadue,Deborah L. French,Philip J. Mason,Monica Bessler,Mitchell J. Weiss
IMMUNOBIOLOGY
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses
Giulia Nizzoli,Jana Krietsch,Anja Weick,Svenja Steinfelder,Federica Facciotti,Paola Gruarin,Annalisa Bianco,Bodo Steckel,Monica Moro,Mariacristina Crosti,Chiara Romagnani,Katharina Stölzel,Sara Torretta,Lorenzo Pignataro,Carmen Scheibenbogen,Petra Neddermann,Raffaele De Francesco,Sergio Abrignani,Jens Geginat
LYMPHOID NEOPLASIA
Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK–mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphoma
Scott R. P. McDonnell,Steven R. Hwang,Delphine Rolland,Carlos Murga-Zamalloa,Venkatesha Basrur,Kevin P. Conlon,Damian Fermin,Thomas Wolfe,Alexander Raskind,Chunhai Ruan,Jian-Kang Jiang,Craig J. Thomas,Cory M. Hogaboam,Charles F. Burant,Kojo S. J. Elenitoba-Johnson,Megan S. Lim
Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience
Daryl Tan,Sandra J. Horning,Richard T. Hoppe,Ronald Levy,Saul A. Rosenberg,Bronislava M. Sigal,Roger A. Warnke,Yasodha Natkunam,Summer S. Han,Alan Yuen,Sylvia K. Plevritis,Ranjana H. Advani
MYELOID NEOPLASIA
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
Scott R. Daigle,Edward J. Olhava,Carly A. Therkelsen,Aravind Basavapathruni,Lei Jin,P. Ann Boriack-Sjodin,Christina J. Allain,Christine R. Klaus,Alejandra Raimondi,Margaret Porter Scott,Nigel J. Waters,Richard Chesworth,Mikel P. Moyer,Robert A. Copeland,Victoria M. Richon,Roy M. Pollock
PLATELETS AND THROMBOPOIESIS
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
TRANSFUSION MEDICINE
TRANSPLANTATION
Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling
Franco Locatelli,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group,Nabil Kabbara,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group,Annalisa Ruggeri,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group,Ardeshir Ghavamzadeh,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group,Irene Roberts,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group,Chi Kong Li,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group,Françoise Bernaudin,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group,Christiane Vermylen,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group,Jean-Hugues Dalle,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group,Jerry Stein,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group,Robert Wynn,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group,Catherine Cordonnier,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group,Fernando Pinto,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group,Emanuele Angelucci,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group,Gérard Socié,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group,Eliane Gluckman,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group,Mark C. Walters,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group,Vanderson Rocha,on behalf of Eurocord and European Blood and Marrow Transplantation (EBMT) group
Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation
Jurjen Versluis,Suzan D. Pas,Hendrik J. Agteresch,Robert A. de Man,Jolanda Maaskant,Marguerite E. I. Schipper,Albert D. M. E. Osterhaus,Jan J. Cornelissen,Annemiek A. van der Eijk
CORRESPONDENCE
-
Cover Image
Cover Image
Immunofluorescence image showing the plasma membrane localization of annexin A2 (green) and S100A10 (red) in forskolin-stimulated human endothelial cells. See the article by Brandherm et al on page 1042.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals